Literature DB >> 26867665

Influence of Ku86 and XRCC4 expression in uterine cervical cancer on the response to preoperative radiotherapy.

Yu Takada1, Masanori Someya1, Yoshihisa Matsumoto2, Masaaki Satoh3, Kensei Nakata1, Masakazu Hori1, Masato Saito1, Naoki Hirokawa1, Kunihiko Tateoka1, Mizue Teramoto4, Tsuyoshi Saito4, Tadashi Hasegawa5, Koh-Ichi Sakata6.   

Abstract

DNA double-strand breaks (DSB) are severe damages induced by ionizing radiation. Non-homologous end joining (NHEJ) is a major mechanism for repairing DSB. Immunohistochemical analysis of proteins involved in NHEJ, such as Ku86 and XRCC4 (X-ray repair cross-complementing protein 4) may be useful for predicting tumor radiosensitivity. We examined the relationship between expression of DSB-related proteins in biopsy specimens of uterine cervical cancer and the pathological effect of 40 Gy of preoperative radiotherapy. 119 patients with uterine cervical cancer were treated between 2000 and 2011. Pathological effects of preoperative radiotherapy were classified by examining hysterectomy specimens. Patients with complete response (pCR) had a significantly better overall 5-year survival rate than those without pCR (96.3 vs. 76.9 %, P = 0.02). The pCR rate was significantly higher in patients with low Ku86 and XRCC4 expression than in other patients (47.4 vs. 21.3 %, P = 0.04). Logistic regression analysis also demonstrated that low Ku86 and XRCC4 expression was a significant predictor of pCR (P = 0.03). Patients with high Ku86 and XRCC4 expression had a significantly lower 5-year metastasis-free rate than others (79.3 vs. 93.5 %, P = 0.02). Proteins involved with NHEJ might have an influence on results of radiotherapy for uterine cervical cancer.

Entities:  

Keywords:  Immunohistochemical staining; Ku86; Radiotherapy; Uterine cervical cancer; XRCC4

Mesh:

Substances:

Year:  2016        PMID: 26867665     DOI: 10.1007/s00795-016-0136-5

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  15 in total

1.  Radiation-induced XRCC4 association with chromatin DNA analyzed by biochemical fractionation.

Authors:  Radhika Pankaj Kamdar; Yoshihisa Matsumoto
Journal:  J Radiat Res       Date:  2010-04-24       Impact factor: 2.724

2.  Expression of genes involved in repair of DNA double-strand breaks in normal and tumor tissues.

Authors:  K Sakata; Y Matsumoto; H Tauchi; M Satoh; A Oouchi; H Nagakura; K Koito; Y Hosoi; N Suzuki; K Komatsu; M Hareyama
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-01-01       Impact factor: 7.038

Review 3.  The DNA-dependent protein kinase, DNA-PK: 10 years and no ends in sight.

Authors:  S P Lees-Miller
Journal:  Biochem Cell Biol       Date:  1996       Impact factor: 3.626

4.  Multi-institutional study of radiation therapy for isolated para-aortic lymph node recurrence in uterine cervical carcinoma: 84 subjects of a population of more than 5,000.

Authors:  Yuzuru Niibe; Masahiro Kenjo; Tomoko Kazumoto; Koichi Michimoto; Makoto Takayama; Chikako Yamauchi; Masaaki Kataoka; Kazunori Suzuki; Noriko Ii; Takashi Uno; Tsuyoshi Takanaka; Keiko Higuchi; Hideya Yamazaki; Sunao Tokumaru; Masahiko Oguchi; Kazushige Hayakawa
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-12-01       Impact factor: 7.038

Review 5.  Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications.

Authors:  Sophie E Polo; Stephen P Jackson
Journal:  Genes Dev       Date:  2011-03-01       Impact factor: 11.361

6.  Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix.

Authors:  A F Fuller; N Elliott; C Kosloff; W J Hoskins; J L Lewis
Journal:  Gynecol Oncol       Date:  1989-04       Impact factor: 5.482

7.  Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20.

Authors:  M Rotman; T F Pajak; K Choi; M Clery; V Marcial; P W Grigsby; J Cooper; M John
Journal:  JAMA       Date:  1995-08-02       Impact factor: 56.272

Review 8.  Identification of genes involved in repair of DNA double-strand breaks in mammalian cells.

Authors:  P A Jeggo
Journal:  Radiat Res       Date:  1998-11       Impact factor: 2.841

9.  The expression pattern of Ku correlates with tumor radiosensitivity and disease free survival in patients with rectal carcinoma.

Authors:  Yasuhiro Komuro; Toshiaki Watanabe; Yoshio Hosoi; Yoshihisa Matsumoto; Keiichi Nakagawa; Nelson Tsuno; Shinsuke Kazama; Joji Kitayama; Norio Suzuki; Hirokazu Nagawa
Journal:  Cancer       Date:  2002-09-15       Impact factor: 6.860

10.  Rationale for using pathologic tumor dimensions and nodal status to subclassify surgically treated stage IB cervical cancer patients.

Authors:  R D Alvarez; M E Potter; S J Soong; F L Gay; K D Hatch; E E Partridge; H M Shingleton
Journal:  Gynecol Oncol       Date:  1991-11       Impact factor: 5.482

View more
  6 in total

1.  Prediction of Results of Radiotherapy With Ku70 Expression and an Artificial Neural Network.

Authors:  Tomokazu Hasegawa; Masanori Someya; Masakazu Hori; Takaaki Tsuchiya; Yuuki Fukushima; Yoshihisa Matsumoto; Koh-Ichi Sakata
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

2.  Prediction of treatment response from the microenvironment of tumor immunity in cervical cancer patients treated with chemoradiotherapy.

Authors:  Masanori Someya; Takaaki Tsuchiya; Yuki Fukushima; Tomokazu Hasegawa; Masakazu Hori; Mio Kitagawa; Toshio Gocho; Shoh Mafune; Yutaro Ikeuchi; Yoshihiko Hirohashi; Toshihiko Torigoe; Masahiro Iwasaki; Motoki Matsuura; Tsuyoshi Saito; Yoshihisa Matsumoto; Koh-Ichi Sakata
Journal:  Med Mol Morphol       Date:  2021-05-08       Impact factor: 2.309

3.  Silencing of XRCC4 increases radiosensitivity of triple-negative breast cancer cells.

Authors:  Yuqing Wen; Gongpeng Dai; Liping Wang; Kanda Fu; Shuguang Zuo
Journal:  Biosci Rep       Date:  2019-03-19       Impact factor: 3.840

Review 4.  Regulation of programmed death-ligand 1 expression in response to DNA damage in cancer cells: Implications for precision medicine.

Authors:  Hiro Sato; Penny A Jeggo; Atsushi Shibata
Journal:  Cancer Sci       Date:  2019-10-04       Impact factor: 6.716

5.  A score of DNA damage repair pathway with the predictive ability for chemotherapy and immunotherapy is strongly associated with immune signaling pathway in pan-cancer.

Authors:  Ke Ding; Youhua He; Jinfen Wei; Shuying Fu; Jiajian Wang; Zixi Chen; Haibo Zhang; Yimo Qu; Keying Liang; Xiaocheng Gong; Li Qiu; Dong Chen; Botao Xiao; Hongli Du
Journal:  Front Immunol       Date:  2022-08-23       Impact factor: 8.786

6.  Prognostic significance of XRCC4 expression in hepatocellular carcinoma.

Authors:  Jun Lu; Xing-Zhizi Wang; Tian-Qi Zhang; Xiao-Ying Huang; Jin-Guang Yao; Chao Wang; Zhong-Hong Wei; Yun Ma; Xue-Min Wu; Chun-Ying Luo; Qiang Xia; Xi-Dai Long
Journal:  Oncotarget       Date:  2017-09-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.